Cargando…
Study Design for an Evaluation of Newborn Screening for SCID in the UK
Severe combined immunodeficiency is a rare inherited disorder, which, if untreated, invariably proves fatal in late infancy or early childhood. With treatment, the prognosis is much improved. Early treatment of the siblings of cases, before they become symptomatic, has shown considerable improvement...
Autor principal: | Elliman, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788435/ https://www.ncbi.nlm.nih.gov/pubmed/35076461 http://dx.doi.org/10.3390/ijns8010004 |
Ejemplares similares
-
Newborn Screening for SCID. Experience in Spain (Catalonia)
por: Argudo-Ramírez, Ana, et al.
Publicado: (2021) -
Newborn Screening for SCID Identifies Patients with Ataxia Telangiectasia
por: Mallott, Jacob, et al.
Publicado: (2012) -
Universal Newborn Screening for Severe Combined Immunodeficiency (SCID)
por: van der Burg, Mirjam, et al.
Publicado: (2019) -
Establishing Newborn Screening for SCID in the USA; Experience in California †
por: Puck, Jennifer M., et al.
Publicado: (2021) -
Flow Cytometry Confirmation Post Newborn Screening for SCID in England
por: Gilmour, Kimberly C.
Publicado: (2021)